Perseon is dedicated to developing innovative technologies to fight cancer. Our products treat soft tissue tumors with precision-focused microwave energy,
expanding treatment options for patients and healthcare providers everywhere.
The one-of-a-kind microwave ablation system providing the perfect balance of precise control, flexibility and power.
Physicians who need to ablate soft tissue tumors, both malignant and benign, prefer the MicroThermX microwave ablation system because its 915 MHz frequency results in a deeper penetration into the tissue.
Physicians get more power and, at the same time, more control when removing tumors in organs such as lung, liver, and kidney.
When larger ablation zones are required physicians rely on the Synchronous Wave Alignment technology of MicroThermX. Using multiple Perseon antenna tips increases the probability of reaching the center of
large tumors and creating larger margins to ensure that all of the surrounding cells are eliminated.
Due to the flexibility of the system physicians use MicroThermX in open surgical procedures and percutaneous ablations. It consists of a single generator and amplifier that deliver microwave energy to single or
CEO Clinton E. Carnell Jr.
Mr. Carnell brings a successful 20+year track record of building companies and creating shareholder value. He recently served as an advisor to Covidien as executive in residence.
From 2011-2014 he was President, Chief Executive and Chairman of myoscience, inc., a silicon valley based medical device company specializing in using cold to treat
peripheral nerve conditions in pain and aesthetics. From 2005-2011, Clint was a key member of the executive team responsible for the turnaround of Thermage, Inc. including a successful IPO
and responsibility for the integration of Reliant to create Solta Medical, Inc. as Chief Operating Officer. Solta later sold to Valeant Pharmaceuticals for 280 million dollars.
Clint holds a Bachelor of Arts degree from Duke University.
2188 W 2200 S
Salt Lake City, UT 84119